ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

NCAB Committee Close To Definition Of QRA

February 11, 1983

Doctors Are Doing More Cancer Screening, ACS Survey Finds

March 30, 1990

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979